The first crop of antivirals against SARS-CoV-2 is promising. But new drugs will be needed to counter the looming threat of resistance.
Credit: YONHAP/EPA-EFE/Shutterstock
“These are our first-generation antivirals against coronaviruses,” says Sara Cherry, an immunologist at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. Our experience with antivirals against other diseases, like hepatitis C and HIV, proves that “we can do better and better over time”, she adds.
It’s too soon to tell whether SARS-CoV-2 is likely to develop any resistance to these first-generation antivirals, says Tim Sheahan, a coronavirologist at the University of North Carolina at Chapel Hill. Although its sky-high rate of replication is a breeding ground for mutations, he says, the virus also causes acute infections that offer relatively little time for resistance-causing mutations to accumulate.
Other antiviral drug candidates are slowly working their way through the clinical-trial pipeline, says Carl Dieffenbach, director of the division of AIDS at the US National Institute of Allergy and Infectious Diseases . He says that one promising candidate is a protease inhibitor, developed by Shionogi & Company, based in Osaka, Japan, and Hokkaido University in Japan, that is currently in phase II/III clinical trials in Asia.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Center for COVID Control facing lawsuit from Minnesota AG alleging widespread COVID testing schemeThe Center for COVID Control is facing a fraud lawsuit filed by Minnesota's attorney general alleging a widespread COVID testing scheme.
Leer más »
Why Are States Sitting on Hundreds of Billions in Unspent COVID Relief Money?According to experts tracking federal COVID spending, as much as $800 billion of the roughly $6 trillion that has been approved by Congress in the last two years for the pandemic is currently unspent
Leer más »
Here’s why Allen’s COVID-19 dashboard isn’t showing city-level dataThroughout the pandemic, the city of Allen’s COVID-19 data dashboard has offered insights into trends at both the state, county and city level. But as of...
Leer más »
Why kids under 5 still can't get a COVID-19 vaccineAfter disappointing results from clinical trials last year, vaccine companies are working to make the shots more effective. Here's where the science stands now.
Leer más »
Two Studies Detail the Dangers of COVID in PregnancyTwo new studies show how COVID-19 threatens the health of pregnant people and their newborn infants, with one showing that unvaccinated pregnant people who got COVID were much more likely to have a stillborn infant or one that dies in the first 28 days.
Leer más »
US begins offering free COVID tests, but many more are neededFor the first time, people across the U.S. can log on to a government website and order free, at-home COVID-19 tests, but the White House push may do little to ease the omicron surge. From the Associated Press.
Leer más »